Choon-Mee Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Choon-Mee Kim has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Dong-Min Kim
Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea
35 shared publications - Na Ra Yun
Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea
25 shared publications - Jun-Won Seo
Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea
9 shared publications - Seok Won Kim
Department of Neurosurgery, College of Medicine, Chosun University, Gwangju, Korea
8 shared publications - Da Young Kim
Division of Infectious Disease, Department of Internal Medicine, College of Medicine, Chosun University, Jeonnam-Gwangju, Republic of Korea
7 shared publications - Na Ra Yun
Department of Internal Medicine, College of Medicine, Chosun University, Gwangju, Korea
5 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 64  (4) , 350-359
Morphological and molecular identification of hard ticks using mitochondrial 16S and 12S rDNA in Korea
Accurate identification of tick species is essential for understanding their role in pathogen transmission and guiding vector control strategies. Although morphological classification is widely used, it can be limited by specimen damage or immature developmental stages. In this study, we comparatively evaluated mitochondrial 16S and 12S ribosomal DNA (rDNA) markers for species-level identification and morphological verification of hard ticks and rodent-associated ectoparasites collected from vegetation, wild rodents, and patients in Gwangju, Republic of Korea. A total of 74 morphologically identified adult ticks—Haemaphysalis longicornis, Haemaphysalis flava, and Ixodes nipponensis—along with 3 damaged ticks removed from patients, were analyzed. PCR and sequencing success varied among species and markers. The 16S rDNA marker showed a higher amplification rate but lower sequencing success, whereas 12S rDNA showed more consistent performance. I. nipponensis showed the most balanced performance (89.5% for 16S and 78.9% for 12S), H. flava showed moderate variation, and H. longicornis demonstrated strong marker dependence, with low 16S but complete 12S success. Importantly, 16S rDNA identified 3 severely damaged ticks from patients—2 I. nipponensis and 1 Amblyomma testudinarium—demonstrating its diagnostic value when morphology was uninformative. Phylogenetic analyses of both markers yielded well-supported clades consistent with morphological identification. Additionally, 12S rDNA identified 3 flea specimens (Ctenophthalmus sp. and Neopsylla specialis) obtained during tick collection from wild rodents, indicating exploratory applicability to other rodent-associated ectoparasites. These findings support mitochondrial 16S and 12S rDNA markers as reliable tools for tick identification, especially when morphological assessment is limited by damage or developmental stage.
- 20 August 2026
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 64  (4) , 350-359
Open AccessMorphological and molecular identification of hard ticks using mitochondrial 16S and 12S rDNA in Korea
Accurate identification of tick species is essential for understanding their role in pathogen transmission and guiding vector control strategies. Although morphological classification is widely used, it can be limited by specimen damage or immature developmental stages. In this study, we comparatively evaluated mitochondrial 16S and 12S ribosomal DNA (rDNA) markers for species-level identification and morphological verification of hard ticks and rodent-associated ectoparasites collected from vegetation, wild rodents, and patients in Gwangju, Republic of Korea. A total of 74 morphologically identified adult ticks—Haemaphysalis longicornis, Haemaphysalis flava, and Ixodes nipponensis—along with 3 damaged ticks removed from patients, were analyzed. PCR and sequencing success varied among species and markers. The 16S rDNA marker showed a higher amplification rate but lower sequencing success, whereas 12S rDNA showed more consistent performance. I. nipponensis showed the most balanced performance (89.5% for 16S and 78.9% for 12S), H. flava showed moderate variation, and H. longicornis demonstrated strong marker dependence, with low 16S but complete 12S success. Importantly, 16S rDNA identified 3 severely damaged ticks from patients—2 I. nipponensis and 1 Amblyomma testudinarium—demonstrating its diagnostic value when morphology was uninformative. Phylogenetic analyses of both markers yielded well-supported clades consistent with morphological identification. Additionally, 12S rDNA identified 3 flea specimens (Ctenophthalmus sp. and Neopsylla specialis) obtained during tick collection from wild rodents, indicating exploratory applicability to other rodent-associated ectoparasites. These findings support mitochondrial 16S and 12S rDNA markers as reliable tools for tick identification, especially when morphological assessment is limited by damage or developmental stage.
- Open Access
- 2 July 2026
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 64  (3) , 274-280
Molecular detection of Bartonella species and Coxiella endosymbiont in human-biting Haemaphysalis longicornis ticks in Korea
Bartonella species are vector-borne pathogens that infect a wide range of hosts, including humans. Although several Bartonella species have been identified in rodents and arthropods in Korea, information on Bartonella detection in ticks removed from human patients remains limited. This study investigated the presence of Bartonella species DNA in human-biting ticks collected in Korea and screened for other tick-associated bacteria, including Coxiella endosymbiont. From January to December 2018, 35 ticks were removed from 29 tick-bitten patients in Jeollanam-do and Gwangju, Korea. Ticks were identified morphologically and molecularly by 16S rRNA gene PCR. The presence of Bartonella species was assessed using nested PCR targeting the 16S-23S internal transcribed spacer (ITS) region. The ticks were identified as Haemaphysalis longicornis (17/35, 48.6%), Amblyomma testudinarium (14/35, 40.0%), and Ixodes nipponensis (4/35, 11.4%). Two H. longicornis ticks tested positive for Bartonella species. Sequencing revealed 99.5% identity with B. bacilliformis isolate GJRITS124 in one tick and 98.9% identity with B. taylorii isolate 190731_HC2 in the other, both previously identified in Apodemus agrarius rodents in Korea. One B. bacilliformis-positive tick was also positive for Coxiella spp., and sequence analysis indicated a Coxiella endosymbiont showing 100.0% identity with the Coxiella-like endosymbiont strain 580. Phylogenetic analysis supported these findings; however, bacterial cultures from PCR-positive tick lysates were negative. This study provides baseline evidence of B. bacilliformis and B. taylorii, as well as Coxiella endosymbiont DNA in human-biting H. longicornis ticks in Korea and highlights the need for continued surveillance.
- 2 July 2026
- Published by Korean Society for Parasitology in Parasites, Hosts and Diseases
- Vol. 64  (3) , 274-280
Open AccessMolecular detection of Bartonella species and Coxiella endosymbiont in human-biting Haemaphysalis longicornis ticks in Korea
Bartonella species are vector-borne pathogens that infect a wide range of hosts, including humans. Although several Bartonella species have been identified in rodents and arthropods in Korea, information on Bartonella detection in ticks removed from human patients remains limited. This study investigated the presence of Bartonella species DNA in human-biting ticks collected in Korea and screened for other tick-associated bacteria, including Coxiella endosymbiont. From January to December 2018, 35 ticks were removed from 29 tick-bitten patients in Jeollanam-do and Gwangju, Korea. Ticks were identified morphologically and molecularly by 16S rRNA gene PCR. The presence of Bartonella species was assessed using nested PCR targeting the 16S-23S internal transcribed spacer (ITS) region. The ticks were identified as Haemaphysalis longicornis (17/35, 48.6%), Amblyomma testudinarium (14/35, 40.0%), and Ixodes nipponensis (4/35, 11.4%). Two H. longicornis ticks tested positive for Bartonella species. Sequencing revealed 99.5% identity with B. bacilliformis isolate GJRITS124 in one tick and 98.9% identity with B. taylorii isolate 190731_HC2 in the other, both previously identified in Apodemus agrarius rodents in Korea. One B. bacilliformis-positive tick was also positive for Coxiella spp., and sequence analysis indicated a Coxiella endosymbiont showing 100.0% identity with the Coxiella-like endosymbiont strain 580. Phylogenetic analysis supported these findings; however, bacterial cultures from PCR-positive tick lysates were negative. This study provides baseline evidence of B. bacilliformis and B. taylorii, as well as Coxiella endosymbiont DNA in human-biting H. longicornis ticks in Korea and highlights the need for continued surveillance.
- Open Access
- 8 January 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112  (1) , 161-166
Analysis of Clinical and Laboratory Profiles of Patients Hospitalized with Hemorrhagic Fever with Renal Syndrome in Southwestern South Korea
: Hemorrhagic fever with renal syndrome (HFRS) is caused by hantaviruses. Data of 34 patients with HFRS hospitalized at Chosun University Hospital, South Korea, between 2010 and 2021 were retrospectively analyzed. Nested reverse transcription polymerase chain reaction (RT-nPCR) targeting the L segment of hantavirus and sequencing were used for diagnosis. Most cases occurred in men and during the months of October through December. Common symptoms were fever, chills, gastrointestinal symptoms, and myalgia. The common laboratory abnormalities were thrombocytopenia, proteinuria, and elevated levels of serum creatinine, aspartate transaminase, alanine transaminase, and lactate dehydrogenase. Approximately 91.2% of patients had the Hantaan virus with a new genotype cluster, whereas 8.8% had the Seoul virus. Seropositivity based on IgM titer >1:32 on admission was noted in 20.6%, and a 4-fold increase in IgG titer of 1:512 was observed in 11.8%. This study demonstrated that RT-nPCR targeting the L segment of hantaviruses is a more reliable diagnostic method compared to serological testing.
- 8 January 2025
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 112  (1) , 161-166
Open AccessAnalysis of Clinical and Laboratory Profiles of Patients Hospitalized with Hemorrhagic Fever with Renal Syndrome in Southwestern South Korea
: Hemorrhagic fever with renal syndrome (HFRS) is caused by hantaviruses. Data of 34 patients with HFRS hospitalized at Chosun University Hospital, South Korea, between 2010 and 2021 were retrospectively analyzed. Nested reverse transcription polymerase chain reaction (RT-nPCR) targeting the L segment of hantavirus and sequencing were used for diagnosis. Most cases occurred in men and during the months of October through December. Common symptoms were fever, chills, gastrointestinal symptoms, and myalgia. The common laboratory abnormalities were thrombocytopenia, proteinuria, and elevated levels of serum creatinine, aspartate transaminase, alanine transaminase, and lactate dehydrogenase. Approximately 91.2% of patients had the Hantaan virus with a new genotype cluster, whereas 8.8% had the Seoul virus. Seropositivity based on IgM titer >1:32 on admission was noted in 20.6%, and a 4-fold increase in IgG titer of 1:512 was observed in 11.8%. This study demonstrated that RT-nPCR targeting the L segment of hantaviruses is a more reliable diagnostic method compared to serological testing.
- Open Access
- 14 October 2024
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 18  (10) , e0012524
Risk factors of thromboembolic events in patients with scrub typhus
Background: Thromboembolic events are a well-recognized cause of in-hospital deaths of patients with infectious diseases. However, thromboembolic events in patients with scrub typhus, caused by Orientia tsutsugamushi have rarely been reported. This study aimed to assess risk factors associated with thromboembolic events in patients with scrub typhus. Methods: All 93 scrub typhus patients’ diagnoses were confirmed serologically or by positive nested polymerase chain reaction (PCR). The clinical and laboratory findings from 12 scrub typhus patients with thromboembolic events and 81 scrub typhus patients with nonthromboembolic events were retrospectively studied. To determine the factors implicated in thromboembolic events, we performed multivariate logistic regression analysis using the six independent factors identified by the univariate analysis. Findings: The mean age of the patients in the thromboembolic group was 76.4 years (median, 76 years), and in nonthromboembolic group it was 64.6 years (median, 65 years) (PP = 0.039; CI 1.230–2700.27)., 2) Taguchi genotype (OR = 41.5; P = 0.028; CI 1.5–1154.6), 3) atrial fibrillation (OR = 9.4; P = 0.034; CI 1.2–74.0), and 4) age (OR = 1.1; P = 0.046; CI 1.0–1.3). Conclusions: Our study suggests that clinicians should be cautious when managing patients with scrub typhus to avoid the development of thromboembolic events, especially in patients with risk factors such as treatment with rifampin, Taguchi genotype, atrial fibrillation, and advanced age.
- 14 October 2024
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 18  (10) , e0012524
Open AccessRisk factors of thromboembolic events in patients with scrub typhus
Background: Thromboembolic events are a well-recognized cause of in-hospital deaths of patients with infectious diseases. However, thromboembolic events in patients with scrub typhus, caused by Orientia tsutsugamushi have rarely been reported. This study aimed to assess risk factors associated with thromboembolic events in patients with scrub typhus. Methods: All 93 scrub typhus patients’ diagnoses were confirmed serologically or by positive nested polymerase chain reaction (PCR). The clinical and laboratory findings from 12 scrub typhus patients with thromboembolic events and 81 scrub typhus patients with nonthromboembolic events were retrospectively studied. To determine the factors implicated in thromboembolic events, we performed multivariate logistic regression analysis using the six independent factors identified by the univariate analysis. Findings: The mean age of the patients in the thromboembolic group was 76.4 years (median, 76 years), and in nonthromboembolic group it was 64.6 years (median, 65 years) (PP = 0.039; CI 1.230–2700.27)., 2) Taguchi genotype (OR = 41.5; P = 0.028; CI 1.5–1154.6), 3) atrial fibrillation (OR = 9.4; P = 0.034; CI 1.2–74.0), and 4) age (OR = 1.1; P = 0.046; CI 1.0–1.3). Conclusions: Our study suggests that clinicians should be cautious when managing patients with scrub typhus to avoid the development of thromboembolic events, especially in patients with risk factors such as treatment with rifampin, Taguchi genotype, atrial fibrillation, and advanced age.
- Open Access
- 16 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12  (8) , 1696
Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19
The spread of COVID-19 has significantly increased research on antiviral drugs and measures such as case isolation and contact tracing. This study compared the effects of lopinavir/ritonavir and remdesivir on COVID-19 patients with a control group receiving no antiviral drugs. Patients confirmed to have a SARS-CoV-2 infection via real-time RT-PCR were divided into three groups: lopinavir/ritonavir, remdesivir, and control. We assessed the efficacy of these drugs in reducing viral load and viral shedding duration using real-time RT-PCR and Vero E6 cell cultures. Lopinavir/ritonavir led to no detectable infectious SARS-CoV-2, with a median viral clearance time of one day, whereas one remdesivir-treated case remained culture-positive until day 12. Lopinavir/ritonavir significantly reduced viral load compared to remdesivir and control groups (p = 0.0117 and p = 0.0478). No infectious virus was detected in the lopinavir/ritonavir group, and the non-infectious SARS-CoV-2 proportion remained constant at 90%, higher than in the remdesivir and control groups (p = 0.0097). There was a significant difference in culture positivity among the groups (p = 0.0234), particularly between the lopinavir/ritonavir and remdesivir groups (p = 0.0267). These findings suggest that lopinavir/ritonavir reduces viral load and shortens the viral shedding duration compared to remdesivir, despite not being an effective treatment option.
- 16 August 2024
- Published by MDPI AG in Microorganisms
- Vol. 12  (8) , 1696
Open AccessComparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19
The spread of COVID-19 has significantly increased research on antiviral drugs and measures such as case isolation and contact tracing. This study compared the effects of lopinavir/ritonavir and remdesivir on COVID-19 patients with a control group receiving no antiviral drugs. Patients confirmed to have a SARS-CoV-2 infection via real-time RT-PCR were divided into three groups: lopinavir/ritonavir, remdesivir, and control. We assessed the efficacy of these drugs in reducing viral load and viral shedding duration using real-time RT-PCR and Vero E6 cell cultures. Lopinavir/ritonavir led to no detectable infectious SARS-CoV-2, with a median viral clearance time of one day, whereas one remdesivir-treated case remained culture-positive until day 12. Lopinavir/ritonavir significantly reduced viral load compared to remdesivir and control groups (p = 0.0117 and p = 0.0478). No infectious virus was detected in the lopinavir/ritonavir group, and the non-infectious SARS-CoV-2 proportion remained constant at 90%, higher than in the remdesivir and control groups (p = 0.0097). There was a significant difference in culture positivity among the groups (p = 0.0234), particularly between the lopinavir/ritonavir and remdesivir groups (p = 0.0267). These findings suggest that lopinavir/ritonavir reduces viral load and shortens the viral shedding duration compared to remdesivir, despite not being an effective treatment option.
- Open Access
SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
Objective: The clinical implications of SARS-CoV-2 RNA viremia in blood (RNAemia) remain uncertain despite gaining more prognostic implications for coronavirus disease 2019 (COVID-19). However, the clinical relevance of SARS-CoV-2 RNAemia has not been well documented. Methods: We conducted a cohort study on 95 confirmed COVID-19 patients and explored the prospects with evidence of SARS-CoV-2 RNAemia in association with various clinical characteristics. We performed reverse transcription-polymerase chain reaction and studied the risk factors of SARS-CoV-2 RNAemia using logistic regression analysis. Results: The presence of SARS-CoV-2 RNAemia in critical or fatal cases was the highest (66.7%), followed by severe (12.5%) and mild to moderate (1.7%) in admission samples. SARS-CoV-2 viral RNAemia was detected on admission and 1st week samples; however, RNAemia was not detected on the samples collected on the second week post-symptom onset. Multiple regression analysis showed that the severity of the disease was an independent predictor of RNAemia (p < 0.021), and the Kaplan–Meier survival curve estimated an increased mortality rate in SARS-CoV-2 RNAemia cases (p < 0.001). Conclusions: Our study demonstrated that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients. Hence, we showed that blood RNAemia might be a critical marker for disease severity and mortality.
Open AccessSARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
Objective: The clinical implications of SARS-CoV-2 RNA viremia in blood (RNAemia) remain uncertain despite gaining more prognostic implications for coronavirus disease 2019 (COVID-19). However, the clinical relevance of SARS-CoV-2 RNAemia has not been well documented. Methods: We conducted a cohort study on 95 confirmed COVID-19 patients and explored the prospects with evidence of SARS-CoV-2 RNAemia in association with various clinical characteristics. We performed reverse transcription-polymerase chain reaction and studied the risk factors of SARS-CoV-2 RNAemia using logistic regression analysis. Results: The presence of SARS-CoV-2 RNAemia in critical or fatal cases was the highest (66.7%), followed by severe (12.5%) and mild to moderate (1.7%) in admission samples. SARS-CoV-2 viral RNAemia was detected on admission and 1st week samples; however, RNAemia was not detected on the samples collected on the second week post-symptom onset. Multiple regression analysis showed that the severity of the disease was an independent predictor of RNAemia (p < 0.021), and the Kaplan–Meier survival curve estimated an increased mortality rate in SARS-CoV-2 RNAemia cases (p < 0.001). Conclusions: Our study demonstrated that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients. Hence, we showed that blood RNAemia might be a critical marker for disease severity and mortality.
- Open Access
Efficacy of Plant-Made Human Recombinant ACE2 against COVID-19 in a Golden Syrian Hamster Model
Coronavirus disease 2019 (COVID-19) is a novel infectious respiratory disease caused by SARS-CoV-2. We evaluated the efficacy of a plant-based human recombinant angiotensin-converting enzyme 2 (hrACE2) and hrACE2-foldon (hrACE2-Fd) protein against COVID-19. In addition, we analyzed the antiviral activity of hrACE2 and hrACE2-Fd against SARS-CoV-2 using real-time reverse-transcription PCR and plaque assays. The therapeutic efficacy was detected using the Golden Syrian hamster model infected with SARS-CoV-2. Both hrACE2 and hrACE2-Fd inhibited SARS-CoV-2 by 50% at concentrations below the maximum plasma concentration, with EC50 of 5.8 μg/mL and 6.2 μg/mL, respectively. The hrACE2 and hrACE2-Fd injection groups showed a tendency for decreased viral titers in nasal turbinate tissues on day 3 after virus inoculation; however, this decrease was not detectable in lung tissues. Histopathological examination on day 9 after virus inoculation showed continued inflammation in the SARS-CoV-2 infection group, whereas decreased inflammation was observed in both the hrACE2 and hrACE2-Fd injection groups. No significant changes were observed at other time points. In conclusion, the potential therapeutic efficacy of plant-based proteins, hrACE2 and hrACE2-Fd, against COVID-19 was confirmed in a SARS-CoV-2-inoculated Golden Syrian hamster model. Further preclinical studies on primates and humans are necessary to obtain additional evidence and determine the effectiveness of these therapies.
Open AccessEfficacy of Plant-Made Human Recombinant ACE2 against COVID-19 in a Golden Syrian Hamster Model
Coronavirus disease 2019 (COVID-19) is a novel infectious respiratory disease caused by SARS-CoV-2. We evaluated the efficacy of a plant-based human recombinant angiotensin-converting enzyme 2 (hrACE2) and hrACE2-foldon (hrACE2-Fd) protein against COVID-19. In addition, we analyzed the antiviral activity of hrACE2 and hrACE2-Fd against SARS-CoV-2 using real-time reverse-transcription PCR and plaque assays. The therapeutic efficacy was detected using the Golden Syrian hamster model infected with SARS-CoV-2. Both hrACE2 and hrACE2-Fd inhibited SARS-CoV-2 by 50% at concentrations below the maximum plasma concentration, with EC50 of 5.8 μg/mL and 6.2 μg/mL, respectively. The hrACE2 and hrACE2-Fd injection groups showed a tendency for decreased viral titers in nasal turbinate tissues on day 3 after virus inoculation; however, this decrease was not detectable in lung tissues. Histopathological examination on day 9 after virus inoculation showed continued inflammation in the SARS-CoV-2 infection group, whereas decreased inflammation was observed in both the hrACE2 and hrACE2-Fd injection groups. No significant changes were observed at other time points. In conclusion, the potential therapeutic efficacy of plant-based proteins, hrACE2 and hrACE2-Fd, against COVID-19 was confirmed in a SARS-CoV-2-inoculated Golden Syrian hamster model. Further preclinical studies on primates and humans are necessary to obtain additional evidence and determine the effectiveness of these therapies.
- Open Access
The Seroprevalence of Severe Fever with Thrombocytopenia Syndrome: An Epidemiological Study of Korean Veterinary Hospital Workers
Severe fever with thrombocytopenia syndrome (SFTS) is a zoonotic tick-borne infectious disease caused by the SFTS virus (SFTSV). Few studies have assessed SFTS seroprevalence among veterinary hospital staff and their awareness of SFTS. From January to May 2021, serum samples from 103 veterinary hospital staff were tested for SFTS using an enzyme-linked immunosorbent assay (ELISA), an immunofluorescence assay, and a 50% plaque reduction neutralization antibody test, which yielded positive results in four (3.9%), three (2.9%), and two (1.9%) participants, respectively. A questionnaire was used for an epidemiological investigation. ELISA positivity was higher among those who lacked awareness of possible animal-to-human SFTS transmission (p = 0.029). SFTS awareness was significantly lower among veterinary hospital staff than among the veterinarians (p < 0.001). Providing staff with training concerning standard precautions and the use of appropriate personal protective equipment is important.
Open AccessThe Seroprevalence of Severe Fever with Thrombocytopenia Syndrome: An Epidemiological Study of Korean Veterinary Hospital Workers
Severe fever with thrombocytopenia syndrome (SFTS) is a zoonotic tick-borne infectious disease caused by the SFTS virus (SFTSV). Few studies have assessed SFTS seroprevalence among veterinary hospital staff and their awareness of SFTS. From January to May 2021, serum samples from 103 veterinary hospital staff were tested for SFTS using an enzyme-linked immunosorbent assay (ELISA), an immunofluorescence assay, and a 50% plaque reduction neutralization antibody test, which yielded positive results in four (3.9%), three (2.9%), and two (1.9%) participants, respectively. A questionnaire was used for an epidemiological investigation. ELISA positivity was higher among those who lacked awareness of possible animal-to-human SFTS transmission (p = 0.029). SFTS awareness was significantly lower among veterinary hospital staff than among the veterinarians (p < 0.001). Providing staff with training concerning standard precautions and the use of appropriate personal protective equipment is important.
- 5 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106  (1) , 45-46
Case Report: The First Borrelia yangtzensis Infection in a Human in Korea
: Borrelia yangtzensis has been identified in rodents and ticks in China and Japan. A 57-year-old woman with bite mark was diagnosed with B. yangtzensis infection via molecular and serological testing. Here, we report the first case of human infection caused by B. yangtzensis in Korea.
- 5 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106  (1) , 45-46
Case Report: The First Borrelia yangtzensis Infection in a Human in Korea
: Borrelia yangtzensis has been identified in rodents and ticks in China and Japan. A 57-year-old woman with bite mark was diagnosed with B. yangtzensis infection via molecular and serological testing. Here, we report the first case of human infection caused by B. yangtzensis in Korea.